Health Dictionary Find a Doctor

Non-alcoholic fatty liver disease MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Parth Vikram Singh, MBBS[3]

Overview

Abdominal MRI may be helpful in the diagnosis of non-alcoholic fatty liver disease. Findings on MRI suggestive of non-alcoholic fatty liver disease include quantification of the hepatic steatosis. MRI has a sensitivity of 96% and specificity of 93% in diagnosing NAFLD. However, it uses is limited because of the cost.

MRI

  • Abdominal MRI may be helpful in the diagnosis of NAFLD.[1][2][3]
  • Findings on MRI suggestive NAFLD include:
  • MRI also helps longitudinal follow-up of patients with non-alcoholic fatty liver disease to check response to therapy
  • Another kind of MRI is magnetic resonance spectroscopy (MRS) which reflects fat in the whole liver like triglycerides in a specific volume; and proton density fat fraction (PDFF).[6]
  • Magnetic resonance imaging-proton density fat fraction has a sensitivity of 77% to 92% and specificity of 87% to 94% for detecting any degree of hepatic steatosis. Magnetic resonance spectroscopy has sensitivity and specificity of approximately 95% to 98%, but these methods are primarily used in clinical trials and specialized centers.[7]

References

  1. “Nonalcoholic Fatty Liver Disease: Diagnosis and Management – American Family Physician”.
  2. “Nonalcoholic Fatty Liver Disease: Diagnosis and Management – American Family Physician”.
  3. Tilg H, Petta S, Stefan N, Targher G (January 2026). “Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review”. JAMA. 335 (2): 163–174. doi:10.1001/jama.2025.19615. PMID 41212550 Check |pmid= value (help).
  4. Ligabue G, Besutti G, Scaglioni R, Stentarelli C, Guaraldi G (2013). “MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends”. Quant Imaging Med Surg. 3 (4): 192–5. doi:10.3978/j.issn.2223-4292.2013.08.01. PMC 3759141. PMID 24040614.
  5. Lee SS, Park SH (2014). “Radiologic evaluation of nonalcoholic fatty liver disease”. World J. Gastroenterol. 20 (23): 7392–402. doi:10.3748/wjg.v20.i23.7392. PMC 4064084. PMID 24966609.
  6. Di Martino M, Koryukova K, Bezzi M, Catalano C (2017). “Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents”. Children (Basel). 4 (8). doi:10.3390/children4080073. PMC 5575595. PMID 28800087.
  7. Tilg H, Petta S, Stefan N, Targher G (January 2026). “Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review”. JAMA. 335 (2): 163–174. doi:10.1001/jama.2025.19615. PMID 41212550 Check |pmid= value (help).

Template:WS Template:WH

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH